ESPR
Esperion Therapeutics, Inc.Company with tickers: ESPR
CIK
1434868
CUSIP
29664W105
Shares Outstanding
257,431,942
Investor Relations
https://investor.esperion.com/
13F Activity (30d)
3 filings
2 filers
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2021-12-31 | $0 | 10-K, filed 2022-02-22 | ||
| 2020-12-31 | $55,000,000 | 10-K, filed 2022-02-22 | ||